Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Cambridge Prognostic Groups"'
Autor:
Harry Gabb, Vincent J. Gnanapragasam
Publikováno v:
BJUI Compass, Vol 5, Iss 7, Pp 662-664 (2024)
Externí odkaz:
https://doaj.org/article/0cbedc87858a4a4cb07f2b71f7f6e86d
Publikováno v:
European Urology Open Science, Vol 49, Iss , Pp 15-22 (2023)
Background: Active surveillance (AS) is a major management option for men with early prostate cancer. Current guidelines however advocate identical AS follow-up for all without considering different disease trajectories. We previously proposed a prag
Externí odkaz:
https://doaj.org/article/9e2bc0ade09049d98f569ff3f7b8b440
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M. G. Parry, T. E. Cowling, A. Sujenthiran, J. Nossiter, B. Berry, P. Cathcart, A. Aggarwal, H. Payne, J. van der Meulen, N. W. Clarke, V. J. Gnanapragasam
Publikováno v:
BMC Medicine, Vol 18, Iss 1, Pp 1-9 (2020)
Abstract Background The five-tiered Cambridge Prognostic Group (CPG) classification is a better predictor of prostate cancer-specific mortality than the traditional three-tiered classification (low, intermediate, and high risk). We investigated radic
Externí odkaz:
https://doaj.org/article/07e55a6523a24f5899abcb57f2dd5e2e
Autor:
Lois Kim, Nicholas Boxall, Anne George, Keith Burling, Pete Acher, Jonathan Aning, Stuart McCracken, Toby Page, Vincent J. Gnanapragasam
Publikováno v:
BMC Medicine, Vol 18, Iss 1, Pp 1-9 (2020)
Abstract Background The clinical pathway to detect and diagnose prostate cancer has been revolutionised by the use of multiparametric MRI (mpMRI pre-biopsy). mpMRI however remains a resource-intensive test and is highly operator dependent with variab
Externí odkaz:
https://doaj.org/article/948bacd653234786bd1129f82526e2fb
Publikováno v:
BMC Medicine, Vol 16, Iss 1, Pp 1-10 (2018)
Abstract Background The purpose of this study is to validate a new five-tiered prognostic classification system to better discriminate cancer-specific mortality in men diagnosed with primary non-metastatic prostate cancer. Methods We applied a recent
Externí odkaz:
https://doaj.org/article/3754ccf9581d4b09ac4a258ad3deb88a
BACKGROUND: Active surveillance (AS) is a major management option for men with early prostate cancer. Current guidelines however advocate identical AS follow-up for all without considering different disease trajectories. We previously proposed a prag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab16d0fb771d11e76b8e0e5805677979
https://www.repository.cam.ac.uk/handle/1810/347479
https://www.repository.cam.ac.uk/handle/1810/347479
Autor:
Light, Alexander, Lophatananon, Artitaya, Keates, Alexandra, Thankappannair, Vineetha, Barrett, Tristan, Dominguez-Escrig, Jose, Rubio-Briones, Jose, Benheddi, Toufik, Olivier, Jonathan, Villers, Arnauld, Babureddy, Kirthana, Abdelmoteleb, Haitham, Gnanapragasam, Vincent J
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 1; Pages: 216
Peer reviewed: True
For men with newly diagnosed prostate cancer, we aimed to develop and validate a model to predict the risk of progression on active surveillance (AS), which could inform more personalised AS strategies. In total, 883 men from
For men with newly diagnosed prostate cancer, we aimed to develop and validate a model to predict the risk of progression on active surveillance (AS), which could inform more personalised AS strategies. In total, 883 men from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32ac21f3693f857214e2b6feb69aad47
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.